Dr Venugopal Medical Associates Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 19-06-2024
- Paid Up Capital ₹ 0.30 M
as on 19-06-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2017)
- Profit 18.83%
(FY 2017)
- Ebitda 20.43%
(FY 2017)
- Net Worth -67.09%
(FY 2017)
- Total Assets -0.01%
(FY 2017)
About Dr Venugopal Medical Associates
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Kaukuntla Rithvik and Kaukuntla Venugopal serve as directors at the Company.
- CIN/LLPIN
U65923TG2012PTC081380
- Company No.
081380
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr Venugopal Medical Associates?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaukuntla Rithvik  | Director | 05-Feb-2013 | Current |
| Kaukuntla Venugopal | Director | 08-Jun-2012 | Current |
Financial Performance and Corporate Structure Insights of Dr Venugopal Medical Associates.
Dr Venugopal Medical Associates Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 18.83% increase in profit. The company's net worth observed a substantial decline by a decrease of 67.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Venugopal Medical Associates?
In 2017, Dr Venugopal Medical Associates had a promoter holding of 65.00% and a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Century Super Speciality Hospitals Private LimitedActive 12 years 8 monthsKaukuntla Rithvik and Kaukuntla Venugopal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr Venugopal Medical Associates?
Unlock and access historical data on people associated with Dr Venugopal Medical Associates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Venugopal Medical Associates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Venugopal Medical Associates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
